Drug intelligence / Profile preview

Lamisil Once (terbinafine)

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Topical
01

Overview

Lamisil Once is a specialized topical antifungal formulation containing terbinafine hydrochloride, designed for the single-dose treatment of tinea pedis (athlete's foot). The product utilizes a film-forming solution (FFS) technology; upon application to the feet, the liquid evaporates to leave a thin, invisible, occlusive film. This film serves as a reservoir, delivering the active ingredient into the stratum corneum where it persists at therapeutic concentrations for approximately 13 days. Terbinafine is an allylamine that acts by inhibiting fungal squalene epoxidase (squalene monooxygenase), a key enzyme in the ergosterol biosynthesis pathway. The resulting deficiency in ergosterol and the intracellular accumulation of squalene disrupt fungal cell membrane integrity and metabolism, leading to rapid fungicidal action.

Brand names
Lamisil Once
Other names
terbinafine film-forming solutionLamisil Solo
02

Targets

SQLE (Squalene monooxygenase)

Beyond the preview

Go deeper on Lamisil Once (terbinafine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lamisil Once (terbinafine).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call